Categories AlphaGraphs, Earnings, Interviews

LDOS Earnings: Highlights of Leidos’ Q2 2023 report

Leidos Holdings, Inc. (NYSE: LDOS) on Tuesday reported an increase in adjusted earnings for the second quarter of 2023. The company also provided guidance for fiscal 2023.

Leidos Q2 2023 earnings infographic

At $3.84 billion, second-quarter revenues were up 7% year-over-year. Revenues of all three operating segments increased during the three-month period.

Unadjusted net income increased to $207 million or $1.50 per share in the June quarter from $171 million or $1.24 per share in the prior-year period. Adjusted profit was $1.80 per share, up 13% from last year.

For fiscal 2023, the company expects revenues to be in the range of $14.9 billion to $15.2 billion, and adjusted earnings per share to be between $6.40 and 6.80.

Prior Performance

  • Leidos Holdings Q4 2022 earnings infographic
  • Leidos-Holdings-Q3-2022-Earnings-Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight